Application no. and date | 23162978.3 (espacenet) (Federated) (European Patent Register), 20160629 | Patent/reg. no. and date | DK/EP 4233846, 20241204 | Publication date | 20230830 | Priority no. and date | US 201562187113 P, 20150630, US 201662298373 P, 20160222, US 201662301429 P, 20160229, US 201662317286 P, 20160401 | EP pub. no. and date |
EP 4233846 20230830 | Effective date | | Applicant/owner | Gilead Sciences, Inc., 333 Lakeside Drive
Foster City, CA 94404, US | Applicant ref. no. | | Inventor | KOZIARA, Joanna, M.,
Foster City, 94404, US, MCCALLISTER, Scott,
Foster City, 94404, US | Representative | | Opponent | | IPC Class | A61K 31/513 (2006.01) , A61K 31/675 (2006.01) , A61K 9/00 (2006.01) , A61K 9/20 (2006.01) , A61K 9/24 (2006.01) , A61K 9/28 (2006.01) , A61P 31/18 (2006.01) , A61P 43/00 (2006.01) | Title | PHARMACEUTICAL FORMULATIONS | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | Enhedspatent registreret | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|